Herbas VPB

Print
EN | LT
LT - Kondensuoti tricikliniai heterocikliniai junginiai, kaip ŽIV integrazės inhibitoriai
EN - FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 491/16 (2006.01)
C07D 471/16 (2006.01)
C07D 487/16 (2006.01)
A61K 31/5025 (2006.01)
A61K 31/5365 (2006.01)
A61P 31/18 (2006.01)
European patent
(11) Number of the document 2997033
(13) Kind of document T
(96) European patent application number 14798188.0
Date of filing the European patent application 2014-04-18
(97) Date of publication of the European application 2016-03-23
(45) Date of publication and mention of the grant of the patent 2017-11-15
(46) Date of publication of the claims translation 2018-02-12
PCT application
(86) Number PCT/CN2014/075685
Date 2014-04-18
PCT application publication
(87) Number WO 2014/183532
Date 2014-11-20
Priority applications
(30) Number Date Country code
201361824739 P 2013-05-17 US
Inventors
(72)
COLEMAN, Paul J., US
HARTINGH, Timothy J., US
RAHEEM, Izzat T., US
SCHREIER, John, US
SISKO, John T., US
WAI, John, US
GRAHAM, Thomas, US
HU, Lihong, CN
PENG, Xuanjia, CN
Grantee
(73) Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Kondensuoti tricikliniai heterocikliniai junginiai, kaip ŽIV integrazės inhibitoriai
  FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS
Last renewal fee
Payment date Validity (years) Amount
2022-04-05 9 208.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2023-04-18